AbbVievsConcentra Group Holdings Parent

ABBV and CON stock compared: price, dividend, valuation and results, from SEC filings.

CON

Concentra Group Holdings Parent, Inc.

$42.55

Value $5.5B

-1.02%
CON's page

AbbVie (ABBV) has a market value of $522B and Concentra Group Holdings Parent (CON) $5.5B. The P/E is 50.7 for ABBV and 25.8 for CON. Dividend yield: ABBV 2.35%, CON 0.59%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABBV$522B

    CON$5.5B

    ABBV is 95 times CON

  • Revenue, 12 months

    ABBV$66.0B

    CON$2.3B

    ABBV is 28 times CON

  • Net income, 12 months

    ABBV$10.3B

    CON$216M

    ABBV is 48 times CON

  • Operating margin

    ABBV32.2%

    CON16.9%

    15.3 points apart

  • ROIC

    ABBV25.7%

    CON15.1%

    10.6 points apart

  • P/E

    ABBV50.7

    CON25.8

    ABBV is 2.0 times CON

  • Dividend yield

    ABBV2.4%

    CON0.6%

    1.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

Prices are not available right now.

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABBVAbbVieCONConcentra Group Holdings Parent

Valuation

ABBVCON
Valuation
Price$295.03$42.55
Market value$522B$5.5B
Enterprise value (EV)$592B$6.9B
P/E50.725.8
P/E, 5-year median57.0–
P/B–10.8
EV/EBIT27.917.5
Free cash flow yield3.6%4.7%

Results and growth

ABBVCON
Results and growth
Revenue, 12 months$66.0B$2.3B
Net income, 12 months$10.3B$216M
Free cash flow, 12 months$18.9B$257M
Earnings per share, 12 months$5.81$1.69
Revenue growth, year on year8.6%13.9%
Revenue growth a year, past+5.9%over 5 years+7.9%over 3 years
EPS growth a year, past-2.8%over 5 years-6.7%over 3 years

Margins and returns on capital

ABBVCON
Margins and returns on capital
Gross margin73.7%29.9%
Operating margin32.2%16.9%
Net margin15.7%9.3%
ROIC25.7%15.1%
ROE–49.5%

Balance sheet

ABBVCON
Balance sheet
Cash$10.8B$86M
Total debt$80.9B$2.1B
Net debt / EBITDA3.23.1
Interest cover7.1×3.6×

Dividends and buybacks

ABBVCON
Dividends and buybacks
Dividend yield2.4%0.6%
Dividend per share, 12 months$6.92$0.25
Dividend growth a year, past+6.6%over 5 years–
Buyback yield0.2%0.4%
Shareholder yield2.5%1.0%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABBV or CON

Didn't find what you were looking for?

Ask us
Which is bigger, AbbVie or Concentra Group Holdings Parent?

By market value, AbbVie ($522B) is about 95.3 times Concentra Group Holdings Parent ($5.5B), at today's prices.

Which pays the higher dividend, ABBV or CON?

The dividend yield at today's price is 2.35% for AbbVie and 0.59% for Concentra Group Holdings Parent. Over the last twelve months they paid $6.92 and $0.25 per share.

What is the P/E of ABBV and CON?

At today's price, the P/E is 50.7 for ABBV and 25.8 for CON. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, AbbVie or Concentra Group Holdings Parent?

Over the last twelve months, the net margin was 15.7% for AbbVie and 9.3% for Concentra Group Holdings Parent, and the operating margin 32.2% and 16.9%. Revenue was $66.0B and $2.3B.

Which is the better investment, AbbVie or Concentra Group Holdings Parent?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.